Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trehalose for treatment of ataxia telangiectasia
IRCT20210413050958N8Phase 2Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Jun 2024
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 2 trial of trehalose in ataxia-telangiectasia (AT), sponsored by Mashhad University of Medical Sciences. Started Jun 2024; status: completed.
02
Drugs
trehalose
03
Conditions
ataxia-telangiectasia (AT)
Beyond the preview
Go deeper on IRCT20210413050958N8.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20210413050958N8.